CancerAppy

Artificial Intelligence to optimize cancer drug development

CancerAppy

to transform the world of cancer research

Novel artificial intelligence platform for drug development and personalized medicine



Our Services

HEALTH CARE ONCOLOGY WORKFLOW

FDA Approved Drugs
Medical indications
Pharmacology toxicities
Drugs interactions
Ongoing clinical studies
European and American guidelines
Molecular Biomarkers for personalized medicine
Real World Data
Best workflow to reduce medical effort

PRECISION MEDICINE SOLUTIONS

Genomic Molecular Alterations
Evaluation of oncogenic molecular panels
Druggable vulnerabilities
Targered agents
Therapeutic opportunities
Drug combinations
Ongoing clinical studies
Identification of best treatment based on propietary algorithms

BIOMARKER AND DRUG DEVELOPER

Genomic molecular alterations
Potential target inhibition
Druggable vulnerabilities
Current clinical development
Competitive landscape
Target population and indication
Evaluation of attrition rate
Pharma intelligent
Identification of best clinical development

[

What we do

This platform uses data from different sources including molecular alterations, scientific results, clinical trials, combinations of compounds, described efficacy, competitive landscape, in addition to side effects or potential interactions, to provide the user with all relevant data in a customized manner, without the necessity to obtain this information through complex consulting dossiers.

In addition, we are developing algorithms that can help to predict the success of a new pharmacological compound through the identification of unmet necessities, empty areas, potential side effects or combinations that would not reach the clinical setting, as well as crowded sectors or areas for business development.